nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0905	0.121	CbGbCtD
Nefazodone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0777	0.104	CbGbCtD
Nefazodone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0602	0.0803	CbGbCtD
Nefazodone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0602	0.0803	CbGbCtD
Nefazodone—ABCB1—Betamethasone—ankylosing spondylitis	0.0505	0.0674	CbGbCtD
Nefazodone—ABCB1—Prednisolone—ankylosing spondylitis	0.0499	0.0665	CbGbCtD
Nefazodone—ABCB1—Prednisone—ankylosing spondylitis	0.0471	0.0628	CbGbCtD
Nefazodone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0466	0.0621	CbGbCtD
Nefazodone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0452	0.0602	CbGbCtD
Nefazodone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0353	0.0471	CbGbCtD
Nefazodone—CYP3A4—Betamethasone—ankylosing spondylitis	0.0303	0.0404	CbGbCtD
Nefazodone—CYP3A4—Prednisolone—ankylosing spondylitis	0.0299	0.0398	CbGbCtD
Nefazodone—ABCB1—Dexamethasone—ankylosing spondylitis	0.0294	0.0392	CbGbCtD
Nefazodone—CYP3A4—Prednisone—ankylosing spondylitis	0.0282	0.0376	CbGbCtD
Nefazodone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0277	0.0369	CbGbCtD
Nefazodone—ABCB1—Methotrexate—ankylosing spondylitis	0.0236	0.0315	CbGbCtD
Nefazodone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0176	0.0235	CbGbCtD
Nefazodone—Myalgia—Methylprednisolone—ankylosing spondylitis	0.000395	0.00158	CcSEcCtD
Nefazodone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.000395	0.00158	CcSEcCtD
Nefazodone—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000393	0.00157	CcSEcCtD
Nefazodone—Flushing—Prednisone—ankylosing spondylitis	0.000391	0.00156	CcSEcCtD
Nefazodone—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000391	0.00156	CcSEcCtD
Nefazodone—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000391	0.00156	CcSEcCtD
Nefazodone—Discomfort—Triamcinolone—ankylosing spondylitis	0.000391	0.00156	CcSEcCtD
Nefazodone—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00039	0.00156	CcSEcCtD
Nefazodone—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000389	0.00156	CcSEcCtD
Nefazodone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000387	0.00155	CcSEcCtD
Nefazodone—Angioedema—Betamethasone—ankylosing spondylitis	0.000385	0.00154	CcSEcCtD
Nefazodone—Angioedema—Dexamethasone—ankylosing spondylitis	0.000385	0.00154	CcSEcCtD
Nefazodone—Stomatitis—Methotrexate—ankylosing spondylitis	0.000383	0.00153	CcSEcCtD
Nefazodone—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000382	0.00153	CcSEcCtD
Nefazodone—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000381	0.00152	CcSEcCtD
Nefazodone—Malaise—Betamethasone—ankylosing spondylitis	0.00038	0.00152	CcSEcCtD
Nefazodone—Malaise—Dexamethasone—ankylosing spondylitis	0.00038	0.00152	CcSEcCtD
Nefazodone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000379	0.00152	CcSEcCtD
Nefazodone—Oedema—Triamcinolone—ankylosing spondylitis	0.000379	0.00152	CcSEcCtD
Nefazodone—Vertigo—Dexamethasone—ankylosing spondylitis	0.000379	0.00151	CcSEcCtD
Nefazodone—Vertigo—Betamethasone—ankylosing spondylitis	0.000379	0.00151	CcSEcCtD
Nefazodone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000378	0.00151	CcSEcCtD
Nefazodone—Syncope—Betamethasone—ankylosing spondylitis	0.000378	0.00151	CcSEcCtD
Nefazodone—Syncope—Dexamethasone—ankylosing spondylitis	0.000378	0.00151	CcSEcCtD
Nefazodone—Infection—Triamcinolone—ankylosing spondylitis	0.000377	0.00151	CcSEcCtD
Nefazodone—Sweating—Methotrexate—ankylosing spondylitis	0.000376	0.0015	CcSEcCtD
Nefazodone—Infection—Methylprednisolone—ankylosing spondylitis	0.000376	0.0015	CcSEcCtD
Nefazodone—Haematuria—Methotrexate—ankylosing spondylitis	0.000374	0.0015	CcSEcCtD
Nefazodone—Shock—Triamcinolone—ankylosing spondylitis	0.000373	0.00149	CcSEcCtD
Nefazodone—Insomnia—Prednisolone—ankylosing spondylitis	0.000373	0.00149	CcSEcCtD
Nefazodone—Alopecia—Prednisone—ankylosing spondylitis	0.000373	0.00149	CcSEcCtD
Nefazodone—Shock—Methylprednisolone—ankylosing spondylitis	0.000372	0.00149	CcSEcCtD
Nefazodone—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00037	0.00148	CcSEcCtD
Nefazodone—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00037	0.00148	CcSEcCtD
Nefazodone—Epistaxis—Methotrexate—ankylosing spondylitis	0.00037	0.00148	CcSEcCtD
Nefazodone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00037	0.00148	CcSEcCtD
Nefazodone—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00037	0.00148	CcSEcCtD
Nefazodone—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000369	0.00148	CcSEcCtD
Nefazodone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000366	0.00147	CcSEcCtD
Nefazodone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000366	0.00146	CcSEcCtD
Nefazodone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000365	0.00146	CcSEcCtD
Nefazodone—Convulsion—Betamethasone—ankylosing spondylitis	0.000365	0.00146	CcSEcCtD
Nefazodone—Hypertension—Betamethasone—ankylosing spondylitis	0.000364	0.00145	CcSEcCtD
Nefazodone—Hypertension—Dexamethasone—ankylosing spondylitis	0.000364	0.00145	CcSEcCtD
Nefazodone—Myalgia—Betamethasone—ankylosing spondylitis	0.000359	0.00143	CcSEcCtD
Nefazodone—Myalgia—Dexamethasone—ankylosing spondylitis	0.000359	0.00143	CcSEcCtD
Nefazodone—Anxiety—Dexamethasone—ankylosing spondylitis	0.000358	0.00143	CcSEcCtD
Nefazodone—Anxiety—Betamethasone—ankylosing spondylitis	0.000358	0.00143	CcSEcCtD
Nefazodone—Discomfort—Dexamethasone—ankylosing spondylitis	0.000355	0.00142	CcSEcCtD
Nefazodone—Discomfort—Betamethasone—ankylosing spondylitis	0.000355	0.00142	CcSEcCtD
Nefazodone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000354	0.00142	CcSEcCtD
Nefazodone—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000353	0.00141	CcSEcCtD
Nefazodone—Pain—Prednisolone—ankylosing spondylitis	0.000353	0.00141	CcSEcCtD
Nefazodone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000352	0.00141	CcSEcCtD
Nefazodone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000352	0.00141	CcSEcCtD
Nefazodone—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00035	0.0014	CcSEcCtD
Nefazodone—Vision blurred—Prednisone—ankylosing spondylitis	0.000346	0.00138	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000345	0.00138	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000345	0.00138	CcSEcCtD
Nefazodone—Oedema—Betamethasone—ankylosing spondylitis	0.000344	0.00138	CcSEcCtD
Nefazodone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000344	0.00138	CcSEcCtD
Nefazodone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000344	0.00138	CcSEcCtD
Nefazodone—Oedema—Dexamethasone—ankylosing spondylitis	0.000344	0.00138	CcSEcCtD
Nefazodone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000343	0.00137	CcSEcCtD
Nefazodone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000342	0.00137	CcSEcCtD
Nefazodone—Infection—Dexamethasone—ankylosing spondylitis	0.000342	0.00137	CcSEcCtD
Nefazodone—Infection—Betamethasone—ankylosing spondylitis	0.000342	0.00137	CcSEcCtD
Nefazodone—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000341	0.00136	CcSEcCtD
Nefazodone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00034	0.00136	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00034	0.00136	CcSEcCtD
Nefazodone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00034	0.00136	CcSEcCtD
Nefazodone—Visual impairment—Methotrexate—ankylosing spondylitis	0.00034	0.00136	CcSEcCtD
Nefazodone—Anaemia—Prednisone—ankylosing spondylitis	0.000339	0.00136	CcSEcCtD
Nefazodone—Shock—Dexamethasone—ankylosing spondylitis	0.000338	0.00135	CcSEcCtD
Nefazodone—Shock—Betamethasone—ankylosing spondylitis	0.000338	0.00135	CcSEcCtD
Nefazodone—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000338	0.00135	CcSEcCtD
Nefazodone—Agitation—Prednisone—ankylosing spondylitis	0.000337	0.00135	CcSEcCtD
Nefazodone—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000337	0.00135	CcSEcCtD
Nefazodone—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000337	0.00135	CcSEcCtD
Nefazodone—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000336	0.00134	CcSEcCtD
Nefazodone—Tachycardia—Betamethasone—ankylosing spondylitis	0.000336	0.00134	CcSEcCtD
Nefazodone—Angioedema—Prednisone—ankylosing spondylitis	0.000335	0.00134	CcSEcCtD
Nefazodone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000334	0.00133	CcSEcCtD
Nefazodone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000333	0.00133	CcSEcCtD
Nefazodone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000333	0.00133	CcSEcCtD
Nefazodone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000333	0.00133	CcSEcCtD
Nefazodone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000333	0.00133	CcSEcCtD
Nefazodone—Malaise—Prednisone—ankylosing spondylitis	0.000331	0.00132	CcSEcCtD
Nefazodone—Vertigo—Prednisone—ankylosing spondylitis	0.00033	0.00132	CcSEcCtD
Nefazodone—Syncope—Prednisone—ankylosing spondylitis	0.000329	0.00132	CcSEcCtD
Nefazodone—Tinnitus—Methotrexate—ankylosing spondylitis	0.000329	0.00131	CcSEcCtD
Nefazodone—Anorexia—Betamethasone—ankylosing spondylitis	0.000328	0.00131	CcSEcCtD
Nefazodone—Anorexia—Dexamethasone—ankylosing spondylitis	0.000328	0.00131	CcSEcCtD
Nefazodone—Urticaria—Prednisolone—ankylosing spondylitis	0.000327	0.00131	CcSEcCtD
Nefazodone—Pain—Triamcinolone—ankylosing spondylitis	0.000324	0.0013	CcSEcCtD
Nefazodone—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000323	0.00129	CcSEcCtD
Nefazodone—Hypotension—Dexamethasone—ankylosing spondylitis	0.000321	0.00129	CcSEcCtD
Nefazodone—Hypotension—Betamethasone—ankylosing spondylitis	0.000321	0.00129	CcSEcCtD
Nefazodone—Convulsion—Prednisone—ankylosing spondylitis	0.000318	0.00127	CcSEcCtD
Nefazodone—Hypertension—Prednisone—ankylosing spondylitis	0.000317	0.00127	CcSEcCtD
Nefazodone—Chills—Methotrexate—ankylosing spondylitis	0.000316	0.00126	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000313	0.00125	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000313	0.00125	CcSEcCtD
Nefazodone—Arthralgia—Prednisone—ankylosing spondylitis	0.000312	0.00125	CcSEcCtD
Nefazodone—Myalgia—Prednisone—ankylosing spondylitis	0.000312	0.00125	CcSEcCtD
Nefazodone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000312	0.00125	CcSEcCtD
Nefazodone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000312	0.00125	CcSEcCtD
Nefazodone—Anxiety—Prednisone—ankylosing spondylitis	0.000311	0.00125	CcSEcCtD
Nefazodone—Alopecia—Methotrexate—ankylosing spondylitis	0.000311	0.00124	CcSEcCtD
Nefazodone—Insomnia—Betamethasone—ankylosing spondylitis	0.000311	0.00124	CcSEcCtD
Nefazodone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000311	0.00124	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000309	0.00124	CcSEcCtD
Nefazodone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000309	0.00123	CcSEcCtD
Nefazodone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000309	0.00123	CcSEcCtD
Nefazodone—Discomfort—Prednisone—ankylosing spondylitis	0.000309	0.00123	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000304	0.00121	CcSEcCtD
Nefazodone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000303	0.00121	CcSEcCtD
Nefazodone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000303	0.00121	CcSEcCtD
Nefazodone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000301	0.0012	CcSEcCtD
Nefazodone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.0003	0.0012	CcSEcCtD
Nefazodone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.0003	0.0012	CcSEcCtD
Nefazodone—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0003	0.0012	CcSEcCtD
Nefazodone—Oedema—Prednisone—ankylosing spondylitis	0.0003	0.0012	CcSEcCtD
Nefazodone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.0003	0.0012	CcSEcCtD
Nefazodone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000299	0.0012	CcSEcCtD
Nefazodone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000299	0.0012	CcSEcCtD
Nefazodone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000299	0.0012	CcSEcCtD
Nefazodone—Infection—Prednisone—ankylosing spondylitis	0.000298	0.00119	CcSEcCtD
Nefazodone—Back pain—Methotrexate—ankylosing spondylitis	0.000297	0.00119	CcSEcCtD
Nefazodone—Shock—Prednisone—ankylosing spondylitis	0.000295	0.00118	CcSEcCtD
Nefazodone—Pain—Betamethasone—ankylosing spondylitis	0.000294	0.00118	CcSEcCtD
Nefazodone—Pain—Dexamethasone—ankylosing spondylitis	0.000294	0.00118	CcSEcCtD
Nefazodone—Tachycardia—Prednisone—ankylosing spondylitis	0.000292	0.00117	CcSEcCtD
Nefazodone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00029	0.00116	CcSEcCtD
Nefazodone—Vision blurred—Methotrexate—ankylosing spondylitis	0.000289	0.00116	CcSEcCtD
Nefazodone—Anorexia—Prednisone—ankylosing spondylitis	0.000286	0.00114	CcSEcCtD
Nefazodone—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000285	0.00114	CcSEcCtD
Nefazodone—Anaemia—Methotrexate—ankylosing spondylitis	0.000284	0.00113	CcSEcCtD
Nefazodone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000283	0.00113	CcSEcCtD
Nefazodone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000283	0.00113	CcSEcCtD
Nefazodone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000281	0.00112	CcSEcCtD
Nefazodone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000281	0.00112	CcSEcCtD
Nefazodone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000279	0.00112	CcSEcCtD
Nefazodone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000279	0.00111	CcSEcCtD
Nefazodone—Malaise—Methotrexate—ankylosing spondylitis	0.000277	0.00111	CcSEcCtD
Nefazodone—Vertigo—Methotrexate—ankylosing spondylitis	0.000276	0.0011	CcSEcCtD
Nefazodone—Leukopenia—Methotrexate—ankylosing spondylitis	0.000275	0.0011	CcSEcCtD
Nefazodone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000273	0.00109	CcSEcCtD
Nefazodone—Urticaria—Betamethasone—ankylosing spondylitis	0.000273	0.00109	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000273	0.00109	CcSEcCtD
Nefazodone—Dizziness—Prednisolone—ankylosing spondylitis	0.000273	0.00109	CcSEcCtD
Nefazodone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000272	0.00109	CcSEcCtD
Nefazodone—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000272	0.00109	CcSEcCtD
Nefazodone—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000272	0.00109	CcSEcCtD
Nefazodone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000272	0.00109	CcSEcCtD
Nefazodone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000272	0.00109	CcSEcCtD
Nefazodone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000271	0.00109	CcSEcCtD
Nefazodone—Insomnia—Prednisone—ankylosing spondylitis	0.000271	0.00108	CcSEcCtD
Nefazodone—Paraesthesia—Prednisone—ankylosing spondylitis	0.000269	0.00108	CcSEcCtD
Nefazodone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000268	0.00107	CcSEcCtD
Nefazodone—Cough—Methotrexate—ankylosing spondylitis	0.000268	0.00107	CcSEcCtD
Nefazodone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000268	0.00107	CcSEcCtD
Nefazodone—Convulsion—Methotrexate—ankylosing spondylitis	0.000266	0.00106	CcSEcCtD
Nefazodone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000264	0.00105	CcSEcCtD
Nefazodone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000261	0.00104	CcSEcCtD
Nefazodone—Chest pain—Methotrexate—ankylosing spondylitis	0.000261	0.00104	CcSEcCtD
Nefazodone—Myalgia—Methotrexate—ankylosing spondylitis	0.000261	0.00104	CcSEcCtD
Nefazodone—Decreased appetite—Prednisone—ankylosing spondylitis	0.00026	0.00104	CcSEcCtD
Nefazodone—Rash—Prednisolone—ankylosing spondylitis	0.00026	0.00104	CcSEcCtD
Nefazodone—Dermatitis—Prednisolone—ankylosing spondylitis	0.00026	0.00104	CcSEcCtD
Nefazodone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000259	0.00103	CcSEcCtD
Nefazodone—Headache—Prednisolone—ankylosing spondylitis	0.000258	0.00103	CcSEcCtD
Nefazodone—Discomfort—Methotrexate—ankylosing spondylitis	0.000258	0.00103	CcSEcCtD
Nefazodone—Constipation—Prednisone—ankylosing spondylitis	0.000256	0.00102	CcSEcCtD
Nefazodone—Confusional state—Methotrexate—ankylosing spondylitis	0.000252	0.00101	CcSEcCtD
Nefazodone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000251	0.001	CcSEcCtD
Nefazodone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00025	0.001	CcSEcCtD
Nefazodone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00025	0.001	CcSEcCtD
Nefazodone—Infection—Methotrexate—ankylosing spondylitis	0.000249	0.000994	CcSEcCtD
Nefazodone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000247	0.000987	CcSEcCtD
Nefazodone—Asthenia—Dexamethasone—ankylosing spondylitis	0.000247	0.000987	CcSEcCtD
Nefazodone—Asthenia—Betamethasone—ankylosing spondylitis	0.000247	0.000987	CcSEcCtD
Nefazodone—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000245	0.00098	CcSEcCtD
Nefazodone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000245	0.000979	CcSEcCtD
Nefazodone—Nausea—Prednisolone—ankylosing spondylitis	0.000245	0.000979	CcSEcCtD
Nefazodone—Pruritus—Dexamethasone—ankylosing spondylitis	0.000243	0.000973	CcSEcCtD
Nefazodone—Pruritus—Betamethasone—ankylosing spondylitis	0.000243	0.000973	CcSEcCtD
Nefazodone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000242	0.000968	CcSEcCtD
Nefazodone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000241	0.000964	CcSEcCtD
Nefazodone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00024	0.000962	CcSEcCtD
Nefazodone—Rash—Triamcinolone—ankylosing spondylitis	0.000239	0.000956	CcSEcCtD
Nefazodone—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000239	0.000955	CcSEcCtD
Nefazodone—Anorexia—Methotrexate—ankylosing spondylitis	0.000239	0.000954	CcSEcCtD
Nefazodone—Rash—Methylprednisolone—ankylosing spondylitis	0.000238	0.000954	CcSEcCtD
Nefazodone—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000238	0.000953	CcSEcCtD
Nefazodone—Urticaria—Prednisone—ankylosing spondylitis	0.000238	0.000951	CcSEcCtD
Nefazodone—Headache—Triamcinolone—ankylosing spondylitis	0.000237	0.000949	CcSEcCtD
Nefazodone—Headache—Methylprednisolone—ankylosing spondylitis	0.000237	0.000947	CcSEcCtD
Nefazodone—Body temperature increased—Prednisone—ankylosing spondylitis	0.000237	0.000947	CcSEcCtD
Nefazodone—Abdominal pain—Prednisone—ankylosing spondylitis	0.000237	0.000947	CcSEcCtD
Nefazodone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000235	0.000941	CcSEcCtD
Nefazodone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000235	0.000941	CcSEcCtD
Nefazodone—Hypotension—Methotrexate—ankylosing spondylitis	0.000234	0.000935	CcSEcCtD
Nefazodone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000228	0.000912	CcSEcCtD
Nefazodone—Dizziness—Betamethasone—ankylosing spondylitis	0.000227	0.000909	CcSEcCtD
Nefazodone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000227	0.000909	CcSEcCtD
Nefazodone—Insomnia—Methotrexate—ankylosing spondylitis	0.000226	0.000905	CcSEcCtD
Nefazodone—Nausea—Triamcinolone—ankylosing spondylitis	0.000225	0.0009	CcSEcCtD
Nefazodone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000225	0.000899	CcSEcCtD
Nefazodone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000225	0.000898	CcSEcCtD
Nefazodone—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000223	0.000892	CcSEcCtD
Nefazodone—Somnolence—Methotrexate—ankylosing spondylitis	0.000223	0.00089	CcSEcCtD
Nefazodone—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000221	0.000882	CcSEcCtD
Nefazodone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00022	0.000881	CcSEcCtD
Nefazodone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000219	0.000874	CcSEcCtD
Nefazodone—Vomiting—Betamethasone—ankylosing spondylitis	0.000219	0.000874	CcSEcCtD
Nefazodone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000218	0.00087	CcSEcCtD
Nefazodone—Rash—Dexamethasone—ankylosing spondylitis	0.000217	0.000867	CcSEcCtD
Nefazodone—Rash—Betamethasone—ankylosing spondylitis	0.000217	0.000867	CcSEcCtD
Nefazodone—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000217	0.000866	CcSEcCtD
Nefazodone—Dermatitis—Betamethasone—ankylosing spondylitis	0.000217	0.000866	CcSEcCtD
Nefazodone—Headache—Dexamethasone—ankylosing spondylitis	0.000215	0.000862	CcSEcCtD
Nefazodone—Headache—Betamethasone—ankylosing spondylitis	0.000215	0.000862	CcSEcCtD
Nefazodone—Asthenia—Prednisone—ankylosing spondylitis	0.000215	0.000859	CcSEcCtD
Nefazodone—Pain—Methotrexate—ankylosing spondylitis	0.000214	0.000856	CcSEcCtD
Nefazodone—Pruritus—Prednisone—ankylosing spondylitis	0.000212	0.000847	CcSEcCtD
Nefazodone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000206	0.000825	CcSEcCtD
Nefazodone—Diarrhoea—Prednisone—ankylosing spondylitis	0.000205	0.000819	CcSEcCtD
Nefazodone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000205	0.000818	CcSEcCtD
Nefazodone—Nausea—Dexamethasone—ankylosing spondylitis	0.000204	0.000817	CcSEcCtD
Nefazodone—Nausea—Betamethasone—ankylosing spondylitis	0.000204	0.000817	CcSEcCtD
Nefazodone—Urticaria—Methotrexate—ankylosing spondylitis	0.000199	0.000795	CcSEcCtD
Nefazodone—Dizziness—Prednisone—ankylosing spondylitis	0.000198	0.000792	CcSEcCtD
Nefazodone—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000198	0.000791	CcSEcCtD
Nefazodone—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000198	0.000791	CcSEcCtD
Nefazodone—Vomiting—Prednisone—ankylosing spondylitis	0.00019	0.000761	CcSEcCtD
Nefazodone—Rash—Prednisone—ankylosing spondylitis	0.000189	0.000755	CcSEcCtD
Nefazodone—Dermatitis—Prednisone—ankylosing spondylitis	0.000189	0.000754	CcSEcCtD
Nefazodone—Headache—Prednisone—ankylosing spondylitis	0.000188	0.00075	CcSEcCtD
Nefazodone—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000184	0.000737	CcSEcCtD
Nefazodone—Asthenia—Methotrexate—ankylosing spondylitis	0.00018	0.000718	CcSEcCtD
Nefazodone—Nausea—Prednisone—ankylosing spondylitis	0.000178	0.000711	CcSEcCtD
Nefazodone—Pruritus—Methotrexate—ankylosing spondylitis	0.000177	0.000708	CcSEcCtD
Nefazodone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000171	0.000685	CcSEcCtD
Nefazodone—Dizziness—Methotrexate—ankylosing spondylitis	0.000166	0.000662	CcSEcCtD
Nefazodone—Vomiting—Methotrexate—ankylosing spondylitis	0.000159	0.000636	CcSEcCtD
Nefazodone—Rash—Methotrexate—ankylosing spondylitis	0.000158	0.000631	CcSEcCtD
Nefazodone—Dermatitis—Methotrexate—ankylosing spondylitis	0.000158	0.000631	CcSEcCtD
Nefazodone—Headache—Methotrexate—ankylosing spondylitis	0.000157	0.000627	CcSEcCtD
Nefazodone—Nausea—Methotrexate—ankylosing spondylitis	0.000149	0.000595	CcSEcCtD
